Combination of NMDA-enhancing and Anti-inflammatory Treatments for Schizophrenia
Clinical trial NCT04917302 · RECRUITING
Trial details
- NCT number
- NCT04917302
- Sponsor
- China Medical University Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-13
- Primary completion
- 2026-11-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.